0001493152-20-000279.txt : 20200106 0001493152-20-000279.hdr.sgml : 20200106 20200106214114 ACCESSION NUMBER: 0001493152-20-000279 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200102 FILED AS OF DATE: 20200106 DATE AS OF CHANGE: 20200106 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BAUM MARK L CENTRAL INDEX KEY: 0001274282 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-35814 FILM NUMBER: 20512003 MAIL ADDRESS: STREET 1: C/O IMPRIMIS PHARMACEUTICALS, INC STREET 2: 12264 EL CAMINO REAL, SUITE 350 CITY: SAN DIEGO STATE: CA ZIP: 92130 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HARROW HEALTH, INC. CENTRAL INDEX KEY: 0001360214 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 450567010 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 12264 EL CAMINO REAL STREET 2: SUITE 350 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: 858-704-4042 MAIL ADDRESS: STREET 1: 12264 EL CAMINO REAL STREET 2: SUITE 350 CITY: SAN DIEGO STATE: CA ZIP: 92130 FORMER COMPANY: FORMER CONFORMED NAME: Imprimis Pharmaceuticals, Inc. DATE OF NAME CHANGE: 20120301 FORMER COMPANY: FORMER CONFORMED NAME: TRANSDEL PHARMACEUTICALS INC DATE OF NAME CHANGE: 20070912 FORMER COMPANY: FORMER CONFORMED NAME: Bywater Resources, Inc DATE OF NAME CHANGE: 20060421 4/A 1 ownership.xml X0306 4/A 2020-01-02 2020-01-06 0 0001360214 HARROW HEALTH, INC. HROW 0001274282 BAUM MARK L C/O HARROW HEALTH, INC. 102 WOODMONT BLVD., SUITE 610 NASHVILLE TN 37205 1 1 0 0 Chief Executive Officer Option - Right to Buy 7.30 2020-01-02 4 A 0 217500 0.00 A 2030-01-02 Common Stock 217500 217500 D Restricted Stock Unit 0 2020-01-02 4 A 0 88000 0.00 A 2023-01-02 Common Stock 88000 88000 D Represents stock options granted under the Issuer's 2017 Stock Incentive and Awards Plan (the "Plan"). The stock options vest in equal quarterly installments over a three-year period. Represents restricted stock units ("RSUs") granted under the Plan. Each RSU represents a contingent right to receive one share of common stock of the Issuer upon the vesting and settlement of the RSU. The RSUs vest and settle in full on the third anniversary of the date of grant. This Form 4 amendment corrects the amount of securities "Acquired" by the reporting person which had been incorrectly described as "Disposed Of" in the originally filed Form 4. /s/ Mark L. Baum 2020-01-06